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Abstract
Background: Periodontitis is the most common human infection affecting tooth-supporting structures. It was shown to play
a role in aggravating atherosclerosis. To deepen our understanding of the pathogenesis of this disease, we exposed human
macrophages to an oral bacteria, Porphyromonas gingivalis (P. gingivalis), either as live bacteria or its LPS or fimbria.
Microarray data from treated macrophages or control cells were analyzed to define molecular signatures. Changes in genes
identified in relevant pathways were validated by RT-PCR.
Methodology/Principal Findings: We focused our analysis on three important groups of genes. Group PG (genes
differentially expressed by live bacteria only); Group LFG (genes differentially expressed in response to exposure to LPS and/
or FimA); Group CG (core gene set jointly activated by all 3 stimulants). A total of 842 macrophage genes were differentially
expressed in at least one of the three conditions compared to naı¨ve cells. Using pathway analysis, we found that group CG
activates the initial phagocytosis process and induces genes relevant to immune response, whereas group PG can de-
activate the phagocytosis process associated with phagosome-lysosome fusion. LFG mostly affected RIG-I-like receptor
signaling pathway.
Conclusion/Significance: In light of the fact that acute infections involve live bacteria while chronic infections involve a
combination of live bacteria and their byproducts, group PG could represent acute P. gingivalis infection while group LFG
could represent chronic P. gingivalis infection. Group CG may be associated with core immune pathways, triggered
irrespective of the specific stimulants and indispensable to mount an appropriate immune response. Implications in acute
vs. chronic infection are discussed.
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Introduction
Porphyromonas gingivalis (P. gingivalis) is a Gram-negative anaerobic
bacterium and is considered to be the major pathogen causing
periodontal disease. Periodontitis is one of the most common
chronic infectious diseases. It leads to destruction of the
attachment apparatus and supporting bone of the teeth. P.
gingivalis has been shown to invade endothelial cells, followed by
activation of pro-inflammatory cells [1]. The bacteria can produce
a variety of virulence factors, including lipopolysaccharide (LPS),
fimbriae A (FimA), proteinases, outer membrane proteins and
specific enzymes [2,3], which can be involved in initiation and
progression of periodontal diseases. P. gingivalis LPS is considered
to be the primary bacterial component causing the production of
pro-inflammatory cytokines and host activation [4], although it
shows low endotoxic activity comparing to enterobacterial LPS
[5]. P. gingivalis FimA is a pivotal factor for mediating the
adherence of bacteria to host cell [6]. It mediates the interaction
between P. gingivalis and Toll-like receptor 2 (TLR2) on the surface
of macrophages, and activates another receptor, complement
receptor 3 (CR3) for intracellular entry [7,8]. P. gingivalis survival
and its ability to cause disease are enhanced in the presence of
robust TLR-2/4-dependent host recognition. This phenomenon
may explain the persistence of P. gingivalis implicated in chronic
infectious and inflammatory lesions [9]. In other words, the
activation of innate immune signaling pathways by Toll-like
receptors may help induce and/or maintain chronic infection [10].
Many studies have been focused on the distinct biological
properties of each component in the pathogenesis of periodontal
disease, but few have considered the cooperative contributions of
coexisting bacteria and virulent components to the development of
infection. The present study addressed the influence of individual
virulence factors either alone or in combinations, in an effort to
explore more complex interactions related to pathogenesis, such as
acute and chronic infection.
From three simple macrophage exposure conditions (P.gingivalis,
LPS and FimA) versus control sample, we propose an in vitromodel
to estimate the combined impact of P. gingivalis and/or its virulence
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factors (i.e. LPS and FimA) on innate immune response in human
macrophages, with analysis at the systems level. The macrophage
genes which were differentially expressed under each of the
conditions versus the control sample were identified. Genes
differentially expressed in multiple conditions were visualized in
a Venn diagram. In addition, we specified three important groups
from the diagram. Functional annotations and pathway analyses of
those groups provided valuable insight into unique components of
the macrophage response to P. gingivalis.
Results
Gene comparisons in three microarray conditions
A total of 842 genes which showed differential expressions
compared to the control were identified and collected from the
microarrays of three macrophage exposing conditions, including
live P.gingivalis, LPS and FimA versus control (sterile broth). The
genes were identified by the threshold of fold change (FC) and
False Discovery Rate (FDR). A Venn diagram representing the
distribution of these genes among the three exposure conditions is
shown in Figure 1. The regions covered multiple conditions
indicate the genes differentially expressed in response to more than
one of the exposure conditions. Accordingly, seven subsets of the
genes can be identified. Subset I, III and VII show that the sets of
the genes specifically respond to a signal stimulus only: live P.
gingivalis, LPS and FimA, respectively. Subset II, IV and VI
indicate the sets of the genes involved in any combination of both
two stimuli, suggesting that the genes are shared to react to the
stimuli. Subset V presents the set of the genes commonly happen
when the macrophages expose to these three stimuli.
Figure 1 shows that macrophages responded to live P. gingivalis
with the highest number of changes (677) in gene expression,
although exposure to individual components also induced
significant changes: LPS (575) and FimA (419). There were 336
genes (subset V) shared among all three conditions. Only 11 genes
were limited to the FimA-only subset (subset VII) while there were
120 to LPS-only subset (subset III), and 218 to live P. gingivalis-only
subset (subset I). In addition, 80.2% of the genes for which
expression was altered in response to FimA were also differentially
expressed in response to both live P. gingivalis and to LPS. It has
long been suggested that macrophages have evolved with an
exquisite sensitivity to the presence of LPS, and activate many
response genes specific to activation by LPS.
To delve more deeply into the macrophage response to live P.
gingivalis versus its LPS and FimA, we focused on three groups for
further analysis. The groups of genes were concatenated from the
previously described seven subsets in the Venn diagram. P.
gingivalis group (PG) selected from subset I includes the genes
differentially expressed in the P. gingivalis-specific condition. The
combination of subsets III, VI, and VII was defined as LPS-FimA
group (LFG) where the genes are differentially expressed only in
the existence of P.gingivalis byproducts, which means that the genes
triggered by either byproduct were included. Finally, the Core
group (CG) extracted from subset V was considered to be a
common gene set that is required for general innate immune
response. These three groups were used for further pathway
analysis.
Enrichment pathway analysis in group PG, LFG and CG
To gain underlying biological insights from the results of gene
expression in these three groups, enrichment pathway analysis was
implemented to uncover the major perturbed pathways under the
specific groups of differentially expressed genes. There were a total
of 842 of genes in three groups; 223 of these genes were functionally
clustered in the various categories of KEGG pathways. Other
available pathway databases, including PANTHER [11], Reactome
[12], and BioCarta, were also implemented for gene annotation
clustering. However, KEGG showed the highest coverage among
total identified genes. Fisher’s exact test was applied to determine
whether the proportion of the genes falling into each category was
significant. The list of the mapping pathways is shown in Table 1. P-
value indicates the probability of forming a group by random
chance. We found 13 pathways that matched significantly
(p,0.001); most of them (11/13) correspond to host defense
mechanisms. According to pathway matching, we expected that
each of the three stimuli, i.e., live P.gingivalis, LPS, fimbriae, would
activate the macrophage through TLR2, a member of Toll-like
receptor signaling pathway recognizing bacterial pathogen (See
Table S1), and also the RIG-I-like receptor signaling pathway, and
start to produce and secrete various types of cytokines for
inflammatory responses. The secreted cytokines then triggered
additional immune responses such as chemokine signaling path-
way(s) and Jak-STAT signaling pathway to induce additional
responses, e.g. migration, cellular polarization, apoptosis, etc. In the
list of the pathways, we found gene sets involved in T cell and B cell
receptor signaling pathways, suggesting that the induced macro-
phage response would be expected to activate T and/or B
lymphocytes. The results of mapping pathways illustrated that live
P.gingivalis and its cell components were able to initiate innate and
adaptive immune responses.
Figure 1. Venn diagram representing the logical relations
among the genes from three macrophage treatment condi-
tions. Macrophage genes differentially regulated in response to live
P.gingivalis, LPS or FimA, compared with controls are shown as yellow,
green and red circles, respectively. According to the logical relations,
the total gene set was divided into 7 subsets. The number of genes in
each part is shown in parentheses. Subset I: Live P. gingivalis-only gene
set, where genes were only apparent in live P. gingivalis treatment.
Subset II: The genes were found in both live P. gingivalis and LPS
treatments, but not in FimA. Subset III: LPS-only gene set. Subset IV: The
genes are found in both live P. gingivalis and FimA treatment, but not in
LPS. Subset V: The genes appeared in three stimuli. Subset VI: The
genes found in both LPS and FimA, but not in live P. gingivalis
treatment. Subset VII: FimA-only gene set.
doi:10.1371/journal.pone.0015613.g001
Bioinformatics Analysis of Macrophages
PLoS ONE | www.plosone.org 2 December 2010 | Volume 5 | Issue 12 | e15613
Notably in the NOD-like receptor signaling pathway responsi-
ble for detecting pathogens and generating the innate immune
response, 93.7% of identified genes were shared (from CG); only
6.3% were found in PG and not in LFG, suggesting that this
fundamental pathway can be triggered by different conditions of
infection. For the RIG-I-like receptor signaling pathway, PG
(7.1%) was poorly represented whereas 42.8% of genes in the
pathway came from LFG, suggesting that several key genes
involved in the pathway are only activated by P.gingivalis
byproducts.
Gene regulation in three groups confirmed by
quantitative real-time PCR
From those significantly regulated pathways identified by
enrichment analysis, several key regulated genes that only mapped
to either PG or LFG were selected and further validated by
quantitative real-time PCR (Figure 2, Table 2). In order to
quantitatively catch the relative changes of differential gene
expressions between PG/control and LPS/control, we parallelly
included FC ratio from both qPCR and microarray in Table 2 in
which PG/control divided by LPS/control. The NFATC1 gene,
selected from PG of the three groups, functioned as a transcription
factor for cytokine genes to activate T cell immune response and
showed up-regulation in both PG/control and LPS/control from
microarray data (Figure 2A). However, PG/control had higher
degree of fold change compared to LPS/control which was
confirmed by qPCR results (Figure 2B). TLR4, which sensitively
detects LPS on Gram-negative bacteria and activates the innate
immune system, was identified from LFG, and the gene was
confirmed by qPCR that highly expression in LPS/control
compared to PG/control. The CD40 gene, functioning as a
inflammatory cytokine induced by TLR2/TLR4- dependent Toll-
like receptor signaling pathway [13], exhibited higher up-
regulation in PG/control than in LPS/control consistent with
the fact that P. gingivalis is known to predominantly engage TLR2
as well as TLR4. However, in qPCR result, the value of up-
regulation in PG/control was less than in LPS/control. FADD is
an adaptor molecule transmitting signals for apoptosis which may
also be important for early T cell development; CASP6 functions
as apoptosis-related cysteine peptidase. Both genes showed higher
up-regulation in PG/control from qPCR data. The SOCS1 gene,
functioning as a key physiological component directly interacting
with cytokine regulators to the immune system, displayed higher
up-regulation in LPS/control. In addition, PKC (protein kinase
C), PI3K (phosphoinositide-3-kinase), and PKA (protein kinase A)
found in multiple pathways, including chemokine signaling,
apoptosis, Jak-STAT signaling, and B cell and T cell receptor
signaling. Both PKC and PKA genes showed higher up-regulation
in PG/control, whereas PI3K gene expressed higher up-regulation
in LPS/control in both qPCR and microarray data. ArfGEF plays
an important role in vesicular transport for endocytosis, and UNG,
uracil-DNA glycosylase, located in the pathway of primary
immunodeficiency, and both genes showed higher up-regulation
in PG/control confirmed by qPCR.
Discussion
The present paper provides a comprehensive analysis of gene
expression from microarray results of macrophages when exposed
to live P. gingivalis and compared to its byproducts: LPS or
fimbriae. Our bioinformatics approach allowed the identification
of gene sets solely expressed when live bacteria are exposed to
macrophages as opposed to bacterial by-products alone or in
combination. Three groups of differentially regulated genes were
identified: PG, LFG, and CG. The PG group was selected from
subset I, with genes differentially expressed only in response to
exposure to live P. gingivalis-specific condition. Group LFG, the
union of subsets III, VI, and VII, included the genes whose
regulation appeared to be altered only in the response to P.gingivalis
byproducts. Group CG represents the gene set activated in both
conditions, which we suggest forms the backbone of human
macrophage immune responses to P.gingivalis infection. Further
study of these groups may identify key genes involved in acute and
Table 1. The list of pathway category mapping from three groups of genes.
Pathway ID Pathway name Count1 Percent2 P-Value3
Fold
enrichment Fisher exact CG 4 PG4 LFG4
04620 Toll-like receptor signaling pathway 22 3.1 1.30E-09 5 2.10E-10 54.5% 22.7% 22.7%
04060 Cytokine-cytokine receptor interaction 35 4.9 5.20E-09 3 1.60E-09 80.0% 5.7% 14.2%
04621 NOD-like receptor signaling pathway 16 2.2 3.70E-08 5.9 5.00E-09 93.7% 6.3% 0.0%
04622 RIG-I-like receptor signaling pathway 14 1.9 9.00E-06 4.5 1.70E-06 50.0% 7.1% 42.8%
04623 Cytosolic DNA-sensing pathway 12 1.7 1.90E-05 5 3.10E-06 66.6% 8.3% 25.0%
04210 Apoptosis 15 2.1 1.90E-05 3.9 4.20E-06 60.0% 26.6% 13.3%
04630 Jak-STAT signaling pathway 19 2.6 1.20E-04 2.8 3.90E-05 57.8% 21.1% 21.1%
04062 Chemokine signaling pathway 20 2.8 4.50E-04 2.4 1.70E-04 65.0% 30.0% 5.0%
05221 Acute myeloid leukemia 10 1.4 8.00E-04 3.9 1.80E-04 50.0% 40.0% 10.0%
05200 Pathways in cancer 27 3.8 2.00E-03 1.9 9.90E-04 59.2% 25.9% 14.8%
04010 MAPK signaling pathway 23 3.2 2.70E-03 2 1.30E-03 69.5% 21.7% 8.6%
04662 B cell receptor signaling pathway 10 1.4 5.00E-03 3 1.50E-03 60.0% 30.0% 0.0%
04660 T cell receptor signaling pathway 12 1.7 7.10E-03 2.5 2.50E-03 58.3% 41.6% 0.0%
1Total count of genes from three groups.
2The proportion of total count versus the number of genes in the pathway.
3Only the mapped pathways with p-value ,0.001 were shown.
4PG indicates P.gingivalis-specific group. LFG indicates LPS and FimA-specific group, and CG presents core group sharing in P.gingivalis and it byproducts. The relative
proportion of each group in the corresponding pathway category.
doi:10.1371/journal.pone.0015613.t001
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chronic stages during infection as well as the shared mechanisms in
both conditions. Our main observation proposes novel clues
potentially involved in phagocytosis during infection process.
We then analyzed the individual contribution of each group
among the mapped pathways (Table 1). CG certainly contributed
the greatest proportion (.50%) to each pathway, referred to here
as the core genes responding to general infection. Also, this result
suggests that the host maintains a conserved defense mechanism
core against different types of bacterial stimuli.
Specific pathways induced by Group PG
A key transcription factor – NFAT, which controls the
production of cytokines for cell proliferation, differentiation and
immune response, displayed up-regulation only in response to
live P.gingivalis infection. NFAT could thus be an early signal for
development of adaptive immune response after live P.gingivalis
infection. In addition, several genes up-regulated in CG: PKC,
MARCKS, and PAP, (See Table S1) relate to the activation of
phagocytosis associated with endocytosis, whereas down-regula-
tion of Cofilin in PG (See Table S1) might inhibit the
phagocytosis process associated with phagosome-lysosome fusion.
Combination of each piece of information suggested that this
phenomenon is similar to the pathogen intracellular invasion
[14]. Those pathogens can enter macrophages through lipid
rafts, cholesterol-enriched microdomains for cellular trafficking
and signaling transduction, and prevent the fusion of phagosome
with late endosome/lysosome [15]. Recently, Wang et al. found
that P. gingivalis can also invade macrophage via lipid rafts [16].
The present data provide novel clues regarding the molecular
control mechanism in phagocytosis pathway during the infection
process.
Specific pathways induced by Group LFG
It is notable that in the RIG-I-like receptor signaling pathway
42.8% of genes were found in LFG but only 6.3% in PG. A small
cluster of genes (RIG-I, MDA5, LGP2 and ISG15; See Table S1)
from LFG was mapped in this pathway, which is responsible for
recognizing viral RNA and activating NF-kB, MAP kinases, and
IRFs that control the release of inflammatory cytokines [17].
Recently, Kong et al. found that LPS from E. coli, by binding to
TLR4, was able to induce the expression of RIG-I in macrophages
which then activated LPS-induced phagocytosis [18]. Wang et al.
found that the LPS-stimulated expression of TNF-a in macro-
phages can be divided into an early phase and a late phase,
wherein the late phase is promoted by induction of RIG-I [19]
while our experimental data included macrophage exposure to
trigger for 2 hours reflecting early phase and future studies will
include later time-points to reflect late phases. Until now, it is not
clear if there is any correlation between RIG-I induced
phagocytosis and the special ‘‘lipid raft’’ style of internalization
of P. gingivalis, which could finally lead to other systematic chronic
diseases. These results suggest an assistant role played by LPS
when P. gingivalis invades the macrophage cells; in another words,
LPS could help initiate and maintain the phagocytosis process.
General inflammatory pathways shared in Group CG
From pathway analysis, CG represents the general signaling
pathways for innate immune response induced by exposure to
Table 2. qPCR validation for selected genes from PG and LFG.
Gene symbol P-value
FC ratio1 by
qPCR
FC ratio1 by
microarray Group EntrezID Gene name Pathway ID2
NFAT(NFATC1) 0.0250 1.58 1.43 PG 4772 Nuclear factor of activated T-cells,
cytoplasmic, calcineurin-dependent 1
04660; 04662
TLR4 0.1771 0.72 0.54 LFG 7099 Toll-like receptor 4 04620
CD40 0.7309 0.82 1.17 PG 958 CD40 molecule, TNF receptor
superfamily member 5
04060; 04620
FADD 0.0419 1.54 0.99 LFG 8772 Fas (TNFRSF6)-associated via death
domain
04210; 05200
CASP6 0.7603 1.25 1.03 PG 839 Caspase 6, apoptosis-related cysteine
peptidase
04210
SOCS1 0.2653 0.66 0.33 LFG 8651 Suppressor of cytokine signaling 04630
PKC(PRKCD) 0.6690 1.22 1.52 PG 5580 Protein kinase C, delta 04062;
PI3K(PI3KR5) 0.2193 0.92 0.50 PG 23533 Phosphoinositide-3-kinase,
regulatory subunit 5
04210; 04620; 04630; 04660;
04662; 05200; 05221
PKA(PRKACB) 0.7916 1.42 1.41 PG 5567 Protein kinase, cAMP-dependent,
catalytic, beta
04010; 04062; 04210
ArfGEF (PSD5) 0.3661 1.13 1.22 PG 23362 Pleckstrin and Sec7 domain
containing 3
04144
UNG 0.0098 1.43 1.06 LFG 7374 Uracil-DNA glycosylase 05340
1FC ratio here indicated the ratio of PG/control over LPS/control.
2The genes involved in the pathways showed in the Table1.
doi:10.1371/journal.pone.0015613.t002
Figure 2. Real-time PCR demonstrates that relative transcription levels for NFATC1, UNG, FADD decrease in PG/LPS treatment while
the level for TLR4 increases. A. Comparison of gene expression between PG/Control and LPS/Control from microarray study. The FADD gene and
UNG gene were selected for validation due to important host gene responding to P.gingivalis infection. B. Comparison of gene expression between
PG/Control and LPS/Control from real-time PCR. Asterisks indicate statistically significant (p,0.05) differences in change of mRNA expression. The fold
change is log2 scale.
doi:10.1371/journal.pone.0015613.g002
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these three stimuli. P. gingivalis and its virulent byproducts bind to
TLRs (mostly TLR2) and induce NFkB-dependent gene
expression via the MyD88-p38 MAPK pathway. The activation
of NFkB and MAPK is quick and helps to produce pro-
inflammatory cytokines, such as TNFa, IL-1b and IL-6. The
NOD-like receptor (NLR) family plays an important role in
intracellular ligand recognition, followed by activation of NFkB
and MAPK, cytokine production and apoptosis pathways. The
produced cytokines can trigger innate or adaptive immune
responses by binding to specific receptors on macrophage and
other immune cell surfaces and resulting in host defense, cell
growth, differentiation, and cell death. The main pathways
involved are summarized in Figure 3, which includes Toll-like
receptor, MAPK, NOD-like receptor, Jak-STAT, chemokines
and apoptosis signaling pathways, and cytokine-cytokine receptor
interactions.
Biological insight from the differential pathways
Phagocytosis has been known to be an important process in host
defense. In addition, for pathogenic invasion it is also an initial stage
of local chronic disease that sometimes develops into distal chronic
disease [8,20,21]. The interaction between pathogen and host cells
can be divided into three situations: 1) the pathogen camouflages itself
to prevent phagocytosis (local chronic infection); 2) the macrophage
captures the pathogen by phagocytosis, and the phagosome
successfully fuses with lysosome (acute infection that resolves); 3) the
pathogen is phagocytosed but prevents the fusion between phago-
some and late endosome/lysosome (local and distal chronic infection).
Several studies have revealed the critical role played by FimA in the
internalization of P. gingivalis into macrophages [7,22]. In our study,
RIG-I and its neighbor genes in the RIG-I-like receptor signaling
pathway were significantly up-regulated in macrophages exposed to
bacterial components but not live P. gingivalis (the LFG but not the
Figure 3. The overall framework of the innate immune response triggered by all three stimuli. Pathways in CG were used in constructing
the general regulatory pathway. Not all the genes shown in this pathway were up- or down-regulated across three conditions. 7 pathways were
involved: Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, Jak-STAT signaling pathway, MAPK signaling pathway, apoptosis,
chemokine signaling pathway, and cytokine-cytokine receptor interaction.
doi:10.1371/journal.pone.0015613.g003
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PG). This result suggests that live P. gingivalis- or its byproducts may
induce phagocytosis via distinct mechanisms, e.g. RIG-I-independent
without fusion, vs. RIG-I-dependent with phagosome-lysosome
fusion, which might pertain to the mechanisms distinguishing
between acute and chronic infection.
Implications in Acute vs. Chronic infections
Given the facts that administration of live bacteria through
multiple routes replicates many of the characteristics seen in acute
infections such as clinical sepsis [23] while chronic infections being
a local insult are usually obtained in animals using bacteria
products such as LPS or fimbria or very low concentration of live
bacteria. [23,24,25] we speculate that the gene set representing
that PG could reflect genes expressed acute infection while LFG
could reflect genes expressed in more chronic infections. Indeed
septic shock which is the epitome of acute infection in animals is
mostly obtained after administration of live bacteria; in contrast
the use of LPS to generate an endotoxic response requires the
animals to be artificially pre-sensitized using drugs like D-
galactosamine which inflict liver toxicity and does not mimic
clinical settings [26,27].
By studying the host responses stimulated by exposing human
macrophages to either live P. gingivalis, LPS and FimA, we
identified pathways involved in both general innate immune
response, as well as potentially distinct effects on phagocytosis
induced by different stimuli. This approach may help to discern
the connection between infectious environments and infection
phase transition from acute to chronic stage. Identification of the
molecular signature from PG, LFG and CG may one day help us
distinguish between acute and chronic infection in clinical
diagnosis.
Materials and Methods
Bacterial strain and macrophage preparation
P. gingivalis 381 (ATCC) was cultured anaerobically, as described
previously [28]. Protein-free LPS from P. gingivalis 381 was
extracted with phenol-water and purified by cesium chloride
isopyknic density gradient ultracentrifugation followed by re-
purification, and FimA was purified by size exclusion chromatog-
raphy, as previously described [28]. The preparation of macro-
phage culture is described in Zhou et al [29].
Exposure of macrophages with P. gingivalis and its
components
Adherent macrophages were infected with live P. gingivalis at
indicated multiplicities of infection (MOI). Live P. gingivalis 381
were diluted in media to a concentration of 56108 bacteria per
50 ml, and added to cultures of macrophages. Purified LPS or
FimA from P. gingivalis was added to cell culture media at indicated
concentrations. Cells were incubated at 37uC in an atmosphere
containing 5% CO2. Cells and supernatants were harvested for
2 hours after incubation with live P. gingivalis or its components.
RNA preparation and microarray analysis
Two hours after infection with P. gingivalis, or treatment with P.
gingivalis LPS, FimA, or saline (control), human macrophages were
washed 3 times with ice cold PBS, and total RNA was extracted
using an RNeasy Mini Kit according to the manufacturer’s
instructions. Three independent experiments were performed for
each condition. Synthesis of cDNA first and second strand was
performed using the GeneChip Expression 3’-Amplification
Reagents One-Cycle cDNA Synthesis Kit (P/N 900431). In vitro
transcription (IVT) was performed using the GeneChip Expression
Amplification Reagents kit-30 reactions (P/N 900449) and was
carried out according to the standard Affymetrix protocols.
Twenty micrograms of IVT material were used on each
GeneChip Human Genome U133 Plus 2.0 array, which contains
approximately 54674 gene probe sets. Hybridization and wash
steps were based on the Affymetrix GeneChip Manual. Scanning
was performed by the GeneChip Scanner 3000 7G scanner with
Affymetrix GCOS v1.3 operating system.
Data processing
The raw Affymetrix CEL files from three replicates for each
condition were collected. The Bioconductor (open source software
framework) packages running under R platform (a free statistical
software environment) were used to process the raw data [30].
First the raw data were read from the CEL files into the object of
class AffyBatch. We compared the expression of genes in
macrophages under three conditions: live P. gingivalis-stimulated
versus control, LPS-stimulated versus control, and FimA-stimu-
lated versus control. For each condition, background correction
and quantile normalization were adjusted by Robust Multichip
Average (RMA) in the Affy package [31], followed by non-specific
filtering (nsFilter) to eliminate the uninformative probe sets whose
inconsistent phenotypes appeared in the three replicated arrays.
The calculation of fold change and adjusted p-value (false
discovery rate, FDR) under different conditions was implemented
by limma package [32]. We selected differentially expressed genes,
both up and down regulation, with fold change $2 and FDR
,0.25 for further analysis. The normalized microarray data and
the gene lists among the subsets can be accessed in supplementary
materials. The microarray data has submitted to Gene Expression
Omnibus database (GEO) and can be public access by GEO
accession number- GSE24897.
Pathway analysis
The three gene groups (PG, LFG and CG) were imported into
DAVID [33] for pathway enrichment analysis. The purpose of
pathway enrichment analysis is to identify pathways with a
significant number of differentially expressed genes, and thereby
connect those genes with corresponding functional feature, i.e. a
pathway. Moreover, the information of up- and down-regulation
of those genes as well as their positions in the pathways can
provide indication of the positive or negative outcome of the
pathway [34,35], which is instrumental to estimate the impact
exerted by the differentially expressed genes on the pathway. Fold
enrichment (FE) is used to estimate the enrichment degree of a
given pathway, which is defined as
FE~
m=M
n=N
where m denotes the number of ‘‘hits’’(mapped genes) in the
pathway, M denotes the number of genes in the pathway, n
denotes the number of ‘‘hits’’ in the background and N denotes the
number of total genes in the background. The p-values are
estimated based on Fisher exact test and its modified version—
EASE score [36], respectively.
DAVID [33] is an online database providing services for
functional annotation and function classification. In the functional
annotation section of DAVID, KEGG pathway (an online tool
provided by Kyoto Encyclopedia of Genes and Genomes [37]) was
selected as the only option for the enrichment analysis with the
background gene set as Human Genome U133 Plus 2.0 Array.
DAVID generated a list of enriched KEGG pathways for each
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uploaded gene set, as well as the corresponding information of p-
value, count, percentage (%), and fold enrichment for each KEGG
pathway. The p-value here stands for EASE score, a modified
Fisher exact p-value, which reflects the probability that the
uploaded list is associated with specific KEGG pathway by
random chance. The pathways with p-value ,0.001 were
considered as significantly enriched pathways. We selected the
pathways from the enrichment list and focused on the differentially
expressed genes which distributed at the neighborhood on the
pathway topology. We also provided a color scheme to present
either up- or down-regulation of expression of the genes that
mapped to KEGG pathways by KEGG IDs converted from
Entrez gene IDs of those genes. A Perl script was used to generate
pathway image files with colored genes through KEGG API.
Quantitative Real Time-PCR validation
We selected 12 of genes mapped to different KEGG pathways for
our microarray validation. The RNA was extracted from human
macrophages with QuickGene RNA tissue kit SII and QuickGene-
810, after macrophage 2-hour infection with P. gingivalis strain 381,
treatment with LPS or saline as described before. Reverse
transcription of RNA (1.5 mg) in each 30 ml of reaction was
performed using iScript cDNA Synthesis kit (Bio-Rad) according to
the manufacturer’s protocol. Primer sequences specific to 12 of
target genes were generated with Beacon Designer software (Bio-
Rad). Quantitative PCR was conducted using the iQ SYBR Green
Supermix (Bio-Rad) in Bio-Rad iCycler. The amounts of mRNA
expression from three independent samples were normalized to that
of GAPDH (Glyceraldehyde 3-phosphate dehydrogenase).
Supporting Information
Table S1 The microarray gene expression data from
three conditions. The list of gene expression in three conditions
shows six types of fold changes, including P. gingivalis/Control,
LPS/Control, FimA/Control, P. gingivalis/LPS, P. gingivalis/FimA
and LPS/FimA.
(XLS)
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